Blemish Dots - Charcoal (10 patches)

Description

BLEMISH DOTS - CHARCOAL is presented in a patch dosage form. Specific details regarding the strength and inactive ingredients are not provided. The physical characteristics of the product are also unspecified.

Uses and Indications

This drug is indicated for the soothing and reduction of redness and irritation associated with blemished skin. It also aids in the absorption of excess oil, promoting faster healing of affected areas.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals are advised to instruct patients to begin by cleansing and drying the face thoroughly, ensuring that any makeup is completely removed. Following this preparation, patients should apply one healing dot, ensuring the sticky side is placed directly over the blemish.

The healing dot should be left in place for a minimum of 6 hours; however, it is permissible for patients to leave it on overnight for enhanced efficacy. Patients may repeat this process as necessary, utilizing a new healing dot for each application.

Contraindications

Use is contraindicated in children due to the risk of accidental ingestion. In the event of swallowing, immediate medical assistance or contact with a Poison Control center is advised.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients that the application of this product may lead to skin irritation and dryness, particularly when used concurrently with other topical acne medications. To minimize the risk of irritation, it is recommended that patients use only one topical acne medication at a time.

In the event of accidental ingestion, it is imperative to seek medical assistance immediately or contact a Poison Control center for guidance. Prompt action is essential to ensure patient safety and appropriate management of any potential adverse effects.

Side Effects

Patients should be aware that this product is for external use only. When using this product, skin irritation and dryness may occur, particularly if another topical acne medication is used concurrently. In such cases, it is advised to limit the use to one topical acne medication at a time to minimize the risk of irritation.

These warnings highlight the importance of monitoring for adverse reactions during treatment, especially in patients who may be using multiple topical agents.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of additional topical agents is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Blemish Dots - Charcoal (10 patches) (salicylic acid 0.5%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control center is recommended.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no information available regarding the use of Blemish Dots - Charcoal (salicylic acid 0.5% patch) during pregnancy. The prescribing information does not provide safety concerns, dosage modifications, or special precautions for pregnant patients. Therefore, healthcare professionals should exercise caution when considering the use of this product in women who are pregnant or may become pregnant, as the potential effects on fetal outcomes are not established. It is advisable to weigh the benefits against any unknown risks when recommending this product to pregnant patients.

Lactation

Nursing mothers should be aware of the potential for excretion of this product in breast milk. There is a risk to breastfed infants when nursing mothers use this product. Healthcare professionals should consider these factors when advising lactating mothers regarding the use of this medication.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of data necessitates careful evaluation of potential risks and benefits.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center without delay. Prompt intervention is crucial to mitigate potential adverse effects associated with the overdose. Healthcare professionals should be prepared to provide comprehensive support and management based on the specific circumstances of the overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children. It is important to emphasize that if the medication is swallowed, patients should seek medical help or contact a Poison Control center immediately. This precaution is vital to ensure the safety and well-being of children who may inadvertently access the medication.

Storage and Handling

The product is supplied in a configuration that ensures optimal handling and storage. It should be stored at room temperature to maintain its efficacy. It is imperative to keep the product out of reach of children to prevent accidental ingestion or misuse. This product is intended for external use only, and appropriate precautions should be taken to ensure it is used as directed.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Blemish Dots - Charcoal (10 patches), including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)